Minims Tetracainehydrochloride Bausch + Lomb Ireland Limited (Tetracaine Hydrochloride)

Tetracaine Hydrochloride, the active ingredient in Minims Tetracainehydrochloride Bausch + Lomb Ireland Limited, is a local anesthetic presented as a sterile ophthalmic solution for ocular use. It provides rapid surface anesthesia of the eye for diagnostic examinations and minor procedures.

GNH USA supplies Minims Tetracainehydrochloride Bausch + Lomb Ireland Limited as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Tetracaine Hydrochloride is a topical ophthalmic anesthetic used to provide surface anesthesia for ocular examinations and minor procedures.

- Diagnostic eye examinations: provides temporary anesthesia of the corneal surface for accurate testing. - Minor ocular surgery: facilitates pre‑operative anesthesia for procedures such as foreign body removal. - Laser eye procedures: enables patient comfort during laser treatments.

Adverse reactions may occur following ocular administration of tetracaine hydrochloride.

Common Side Effects: - Transient stinging or burning sensation at the application site. - Mild conjunctival hyperemia (redness). - Temporary blurred vision.

Serious or Rare Side Effects: - Corneal epithelial toxicity or ulceration. - Severe allergic reaction, including anaphylaxis. - Persistent corneal ulceration or infection.

Careful consideration of patient history and handling is essential when using tetracaine hydrochloride ophthalmic solution.

- Allergy assessment: avoid use in patients with known hypersensitivity to tetracaine or other ester anesthetics. - Contact lens use: discontinue lenses prior to administration. - Duration of use: limit exposure to the shortest time necessary for the procedure. - Systemic absorption: monitor for signs of systemic toxicity if large ocular areas are treated. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature: keep in original container, protect from light and moisture.

Tetracaine hydrochloride may interact with other ophthalmic agents, requiring attention to avoid additive toxicity.

Major Interactions (Avoid): - Concurrent use with other ophthalmic anesthetics: may increase risk of corneal toxicity. - Systemic vasoconstrictors (e.g., phenylephrine eye drops): may potentiate local vasoconstriction.

Moderate Interactions (Monitor Closely): - Topical antibiotics: monitor for delayed wound healing. - Anti‑inflammatory eye drops: may mask signs of irritation. - Systemic sodium channel blockers (e.g., antiarrhythmics): observe for additive effects.